Logo image of CLARI.PA

CLARIANE SE (CLARI.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:CLARI - FR0010386334 - Common Stock

3.874 EUR
+0.02 (+0.57%)
Last: 1/20/2026, 7:00:00 PM
Fundamental Rating

3

Overall CLARI gets a fundamental rating of 3 out of 10. We evaluated CLARI against 30 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CLARI have multiple concerns. CLARI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CLARI had negative earnings in the past year.
  • CLARI had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CLARI reported negative net income in multiple years.
  • In the past 5 years CLARI always reported a positive cash flow from operatings.
CLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFCLARI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • With a Return On Assets value of -0.43%, CLARI is not doing good in the industry: 76.67% of the companies in the same industry are doing better.
  • CLARI's Return On Equity of -1.71% is on the low side compared to the rest of the industry. CLARI is outperformed by 76.67% of its industry peers.
  • The Return On Invested Capital of CLARI (1.62%) is worse than 80.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CLARI is below the industry average of 6.46%.
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROIC 1.62%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
CLARI.PA Yearly ROA, ROE, ROICCLARI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

  • CLARI has a Operating Margin of 4.79%. This is comparable to the rest of the industry: CLARI outperforms 56.67% of its industry peers.
  • CLARI's Operating Margin has declined in the last couple of years.
  • CLARI has a better Gross Margin (91.90%) than 96.67% of its industry peers.
  • In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
Industry RankSector Rank
OM 4.79%
PM (TTM) N/A
GM 91.9%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
CLARI.PA Yearly Profit, Operating, Gross MarginsCLARI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1

2. Health

2.1 Basic Checks

  • CLARI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CLARI has more shares outstanding than it did 1 year ago.
  • CLARI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CLARI has an improved debt to assets ratio.
CLARI.PA Yearly Shares OutstandingCLARI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CLARI.PA Yearly Total Debt VS Total AssetsCLARI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • CLARI has an Altman-Z score of 0.62. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CLARI (0.62) is worse than 83.33% of its industry peers.
  • The Debt to FCF ratio of CLARI is 13.25, which is on the high side as it means it would take CLARI, 13.25 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 13.25, CLARI is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
  • CLARI has a Debt/Equity ratio of 1.90. This is a high value indicating a heavy dependency on external financing.
  • CLARI has a worse Debt to Equity ratio (1.90) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Altman-Z 0.62
ROIC/WACC0.38
WACC4.22%
CLARI.PA Yearly LT Debt VS Equity VS FCFCLARI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that CLARI may have some problems paying its short term obligations.
  • With a Current ratio value of 0.67, CLARI is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
  • CLARI has a Quick Ratio of 0.67. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLARI has a Quick ratio (0.65) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.65
CLARI.PA Yearly Current Assets VS Current LiabilitesCLARI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.92% over the past year.
  • The Revenue has been growing slightly by 2.70% in the past year.
  • CLARI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.89% yearly.
EPS 1Y (TTM)84.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%

3.2 Future

  • Based on estimates for the next years, CLARI will show a very strong growth in Earnings Per Share. The EPS will grow by 34.80% on average per year.
  • Based on estimates for the next years, CLARI will show a small growth in Revenue. The Revenue will grow by 2.96% on average per year.
EPS Next Y130.5%
EPS Next 2Y74.69%
EPS Next 3Y53.72%
EPS Next 5Y34.8%
Revenue Next Year0.99%
Revenue Next 2Y2.46%
Revenue Next 3Y3.12%
Revenue Next 5Y2.96%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLARI.PA Yearly Revenue VS EstimatesCLARI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B
CLARI.PA Yearly EPS VS EstimatesCLARI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CLARI. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 15.04 indicates a correct valuation of CLARI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLARI is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of CLARI to the average of the S&P500 Index (23.94), we can say CLARI is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.04
CLARI.PA Price Earnings VS Forward Price EarningsCLARI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • CLARI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLARI is cheaper than 66.67% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CLARI is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.24
EV/EBITDA 8.45
CLARI.PA Per share dataCLARI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • CLARI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CLARI's earnings are expected to grow with 53.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.69%
EPS Next 3Y53.72%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.73, CLARI pays a better dividend. On top of this CLARI pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, CLARI pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.64%

5.2 History

  • The dividend of CLARI decreases each year by -7.26%.
Dividend Growth(5Y)-7.26%
Div Incr Years0
Div Non Decr Years0
CLARI.PA Yearly Dividends per shareCLARI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.05 0.1 0.15 0.2

5.3 Sustainability

  • CLARI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-110.94%
EPS Next 2Y74.69%
EPS Next 3Y53.72%
CLARI.PA Yearly Income VS Free CF VS DividendCLARI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

CLARIANE SE

EPA:CLARI (1/20/2026, 7:00:00 PM)

3.874

+0.02 (+0.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-27
Earnings (Next)02-26
Inst Owners45.31%
Inst Owner ChangeN/A
Ins Owners5.61%
Ins Owner ChangeN/A
Market Cap1.38B
Revenue(TTM)5.31B
Net Income(TTM)-61.38M
Analysts77.14
Price Target4.51 (16.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.64%
Yearly Dividend0.19
Dividend Growth(5Y)-7.26%
DP-110.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.37%
PT rev (3m)-5.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-56.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.04
P/S 0.26
P/FCF 2.24
P/OCF 1.57
P/B 0.39
P/tB N/A
EV/EBITDA 8.45
EPS(TTM)-0.16
EYN/A
EPS(NY)0.26
Fwd EY6.65%
FCF(TTM)1.73
FCFY44.69%
OCF(TTM)2.47
OCFY63.87%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.43%
ROE -1.71%
ROCE 2.21%
ROIC 1.62%
ROICexc 1.74%
ROICexgc 3.52%
OM 4.79%
PM (TTM) N/A
GM 91.9%
FCFM 11.63%
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexgc growth 3Y-9.02%
ROICexgc growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.9
Debt/FCF 13.25
Debt/EBITDA 6.54
Cap/Depr 33.65%
Cap/Sales 4.99%
Interest Coverage 0.83
Cash Conversion 84.73%
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.65
Altman-Z 0.62
F-Score6
WACC4.22%
ROIC/WACC0.38
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y130.5%
EPS Next 2Y74.69%
EPS Next 3Y53.72%
EPS Next 5Y34.8%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year0.99%
Revenue Next 2Y2.46%
Revenue Next 3Y3.12%
Revenue Next 5Y2.96%
EBIT growth 1Y-22.4%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year283.2%
EBIT Next 3Y64.52%
EBIT Next 5Y37.45%
FCF growth 1Y267.45%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%

CLARIANE SE / CLARI.PA FAQ

What is the fundamental rating for CLARI stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLARI.PA.


Can you provide the valuation status for CLARIANE SE?

ChartMill assigns a valuation rating of 5 / 10 to CLARIANE SE (CLARI.PA). This can be considered as Fairly Valued.


What is the profitability of CLARI stock?

CLARIANE SE (CLARI.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for CLARI stock?

The dividend rating of CLARIANE SE (CLARI.PA) is 5 / 10 and the dividend payout ratio is -110.94%.